Targeting the <scp>ABCG</scp>2‐overexpressing multidrug resistant (<scp>MDR</scp>) cancer cells by <scp>PPAR</scp>γ agonists
Kenneth K.W. To(Riverview Hospital), Brian Tomlinson(Macau University of Science and Technology)
Cited by 35
Related Papers
MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside
|World Journal of Gastroenterology|2018|205
Suppression of Hypoxia-inducible Factor 1α (HIF-1α) Transcriptional Activity by the HIF Prolyl Hydroxylase EGLN1
|Journal of Biological Chemistry|2005|113
Small-molecule agents for cancer immunotherapy
|Acta Pharmaceutica Sinica B|2023|53
The role of <b><i>β</i></b>-blockers in the management of hypertension: An Asian perspective
|Current Medical Research and Opinion|2011|14